Expression of p21WAF1/CIP1 during mouse odontogenesis

European Journal of Oral Sciences

Volumn 106, Issue 1 SUPPL., 1998, Pages 104-111

  Bloch Zupan, A ^a,b   Leveillard, T ^c   Gorry, P ^d   Fausser, J L ^a   Ruch, J V ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cellular differentiation; Odontogenesis; Organ culture; p21; Retinoic acid

Indexed keywords

CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MESSENGER RNA; RETINOIC ACID;

AMELOBLAST; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; METABOLISM; MOUSE; ODONTOBLAST; PHYSIOLOGY; TOOTH DEVELOPMENT;

AMELOBLASTS; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; ODONTOBLASTS; ODONTOGENESIS; RNA, MESSENGER; TRETINOIN;

EID: 0031601205     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.1998.tb02160.x     Document Type: Article

References (59)

1. HARTER ML. Molecules that regulate the cell cycle. MedGene Sci 1996; 2: 3-4.
2. SHERR CJ, ROBERTS JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-1163.
3. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, LIU Q, HARSHMAN K, TAVTIGIAN SV, STOCKERT E, DAY RS, JOHNSON BE, SKOLNICK MH. A cell cycle regulator involved in genesis of many tumor types. Science 1994; 264: 436-440.
4. HUNTER T, PINES J. Cyclins and cancer. II. cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
5. EL-DEIRY WS, TOKINO T, VELCULESCU VE, LEVY DB, PARSONS R, TRENT JM, LIN D, MERCER WE, KINZLER KW, VOGELSTEIN B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
6. XIONG Y, HANNON GJ, ZHANG H, CASSO D, KOBAYASHI R, BEACH D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-704.
7. HARPER JW, ADAMI GR, WEI N, KEYOMARSI K, ELLEDGE SJ. The p21 Cdk-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
8. NODA A, NING Y, VENABLE SF, PEREIRA-SMITH OM, SMITH JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 201: 90-98.
9. GU Y, TURCK CW, MORGAN DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366: 707-710.
10. JIANG H, LIN J, SU ZZ, COLLART FR, HUBERMAN E, FISHER PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994; 9: 3397-3406.
11. HUPPI K, SIWARSKI D, DOSIK J, MICHIELI P, CHEDID M, REED S, MOCK B, GIVOL D, MUSHINSKI JF. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21(Waf1). Oncogene 1994; 9: 3017-3020.
12. HARPER JW, ELLEDGE SJ, KEYOMARSI K, DYNLACHT B, TSAI LH, ZHANG P, DOBROWOLSKI S, BAI C, CONNELL-CROWLEY L, SWINDELL E, FOX MP, WEI N. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400.
13. ZHANG H, HANNON GJ, BEACH D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8: 1750-1758.
14. BEAUCHAMP RD, SHENG HM, SHAO JY, THOMPSON EA, Ko TC. Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cipl. Ann Surg 1996; 223: 620-627.
15. FLORES-ROZAS H, KELMAN Z, DEAN FB, PAN Z, HARPER JW, ELLEDGE SJ, O'DONNELL M, HURWITZ J. Cdk-interacting protein-1 (Cip1, WAF1) directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by DNA polymerase δ holoenzyme. Proc Natl Acad Sci USA 1994; 91: 8655-8659.
16. LI CY, SUARDET L, LITTLE JB. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994; 9: 3389-3396.
17. CHEN J, PETERS R, SAHA P, LEE P, THEODORAS A, PAGANO M, WAGNER G, DUTTA A. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res 1996; 24: 1727-1733.
18. CHEN IT, AKAMATSU M, SMITH ML, LUNG FD, DUDA D, ROLLER PP, FORNACE AJ, O'CONNOR PM. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 1996; 12: 595-607.
19. MCDONALD ER, WU GS, WALDMAN T, EL-DEIRY WS. Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res 1996; 56: 2250-2255.
20. MICHIELI P, CHEDID M, LIN D, PIERCE JH, MERCER WE, GIVOL D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-3395.
21. AKASHI M, HACHIYA M, OSAWA Y, SPIRIN K, SUZUKI G, KOEFFLER HP. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 1995; 270: 19181-19187.
22. MACLEOD KF, SHERRY N, HANNON G, BEACH D, TOKINO T, KINZLER K, VOGELSTEIN B, JACKS T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935-944.
23. HALEVY O, NOVITCH BG, SPICER DB, SKAPEK SX, RHEE J, HANNON GJ, BEACH D, LASSAR AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018-1021.
24. WU H, WADE M, KRALL L, GRISHAM J, XIONG Y, VAN DYKE T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev 1996; 10: 245-260.
25. WAF1/CIP1 and terminal differentiation control of normal epithelia. Mol Cell Diff 1996; 4: 1-16.
26. Cip1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024-1027.
27. AHMAD N, RUCH JV. Comparison of growth and cell proliferation kinetics during mouse molar odontogenesis in vivo and in vitro. Cell Tissue Kinet 1987; 20: 319-329.
28. OLIVE M, RUCH JV. Does the basement membrane control the mitotic activity of the inner dental epithelium of the embryonic mouse first molar? Dev Biol 1982; 93: 301-307.
29. RUCH JV. Patterned distribution of differentiating dental cells: facts and hypotheses. J Biol Buccale 1990; 18: 91-98.
30. NSO M, SENGER B, RUCH JV. Scoring mitotic activity in longitudinal sections of mouse embryonic incisors: significant differences exist for labial and lingual inner dental epithelia. J Craniofac Genet Dev Biol 1992; 12: 159-166.
31. RUCH JV. Tooth crown morphogenesis and cytodifferentiations: candid questions and critical comments. Connect Tissue Res 1995; 31: 1-8.
32. THESLEFF I, NIEMINEN P. Tooth morphogenesis and cell differentiation. Curr Opin Cell Biol 1996; 8: 844-850.
33. THESLEFF I, VAAHTOKARI A, VAINIO S, JOWETT A. Molecular mechanisms of cell and tissue interactions during early tooth development. Anal Rec 1996; 245: 151-161.
34. OSUMI-YAMASHITA N, NINOMIYA Y, ETO K. Mammalian craniofacial embryology in vitro. Int J Dev Biol 1997; 41: 187-194.
35. RUCH JV, LESOT H, CAM Y, MEYER JM, BLOCH-ZUPAN A. Control of odontoblast differentiation: current hypotheses. In: SHIMONO M et al., eds. Dentin/pulp complex, Proceedings of the International Conference on Dentin/pulp Complex, 1995. Tokyo: Quintessence Publishing Co., 1996; 105-111.
36. KARCHER-DJURICIC V, STAUBLI A, MEYER JM, RUCH JV. Acellular dental matrices promote functional differentiation of ameloblasts. Differentiation 1985; 29: 169-175.
37. AMAR S, LUO W, SNEAD ML, RUCH JV. Amelogenin gene expression in mouse incisor heterotopic recombinations. Differentiation 1989; 41: 56-61.
38. SNEAD ML, LUO W, LAU EC, SLAVKIN HC. Spatial and temporal pattern for amelogenin gene expression during mouse molar tooth organogenesis. Development 1988; 104: 77-85.
39. RUCH JV. Odontoblast differentiation and the formation of odontoblast layer. J Dent Res 1985; 64: 489-498.
40. RUCH JV, KARCHER-DJURICIC V, THIEBOLD J. Cell division and cytodifferentiation of odontoblasts. Differentiation 1976; 5: 165-169.
41. RUCH JV, LESOT H, KARCHER-DJURICIC V, MEYER JM, OLIVE M. Facts and hypotheses concerning the control of odontoblast differentiation. Differentiation 1982; 21: 7-12.
42. MARK MP, BLOCH-ZUPAN A, RUCH JV. Effects of retinoids on tooth morphogenesis and cytodifferentiations, in vitro. Int J Dev Biol 1992; 36: 517-526.
43. BLOCH-ZUPAN A, MARK MP, WEBER B, RUCH JV. In vitro effects of retinoic acid on mouse incisor development. Arch Oral Biol 1994; 39: 891-900.
44. DÉCIMO D, GEORGES-LABOUESSE E, DOLLÉ P. In situ hybridization of nucleic acid probes to cellular RNA. In: HAMES BD, HIGGINS S, eds. Gene probes 2: a practical approach. Oxford: Oxford University Press, 1995; 183-210.
45. RUCH JV, KARCHER-DJURICIC V, OSMAN M, MEYER JM, LESOT H. Action of 5-bromodeoxyuridine on tooth germs "in vitro". I - Effects on cytodifferentiation. J Biol Buccale 1978; 6: 267-279.
46. LESOT H, VONESCH JL, PETERKA M, TURECKOVA J, PETERKOVA R, RUCH JV. Mouse molar morphogenesis revisited by three-dimensional reconstruction. II. Spatial distribution of mitoses and apoptosis in cap to bell staged first and second upper molar. Int J Dev Biol 1996; 40: 1017-1031.
47. PETERKOVA R, LESOT H, VONESCH JL, PETERKA M, RUCH JV. Mouse molar morphogenesis revisited by three dimensional reconstruction. I. Analysis of initial stages of the first upper molar development revealed two transient buds. Int J Dev Biol 1996; 40: 1009-1016.
48. OSMAN A, RUCH JV. Repartition topographique des mitoses dans l'incisive et la première molaire inférieure de l'embryon de souris. J Biol Buccale 1976; 4: 331-348.
49. WAF1/CIP1 in malignant melanoma. Am J Pathol 1996; 149: 1813-1822.
50. BLOCH-ZUPAN A, DÉCIMO D, LORIOT M, MARK MP, RUCH JV. Expression of nuclear retinoic acid receptors during mouse odontogenesis. Differentiation 1994; 57: 195-203.
51. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 1996; 271: 31723-31728.
52. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142-153.
53. DAVIDEAU JL, PAPAGERAKIS P, HOTTON D, LEZOT F, BERDAL A. In situ investigation of vitamin D receptor, alkaline phosphatase, and osteocalcin gene expression in oro-facial mineralized tissues. Endocrinology 1996; 137: 3577-3585.
54. BAILLEUL-FORESTIER I, DAVIDEAU JL, PAPAGERAKIS P, NOBLE I, NESSMANN C, PEUCHMAUR M, BERDAL A. Immunolocalization of vitamin D receptor and calbindin-D28k in human tooth germ. Pediatr Res 1996; 39: 636-642.
55. SALTIS J. TGF-beta: receptors and cell cycle arrest. Mol Cell Endocrinol 1996; 116: 227-232.
56. DATTO MB, YU Y, WANG XF. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 1995; 270: 28623-28628.
57. AKAGI M, YASUI W, AKAMA Y, YOKOZAKI H, TAHARA H, HARUMA K, KAJIYAMA G, TAHARA E. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn J Cancer Res 1996; 87: 377-384.
58. BEGUE-KIRN C, SMITH AJ, LORIOT M, KUPFERLE C, RUCH JV, LESOT H. Comparative analysis of TGFβs, BMPs, IGF1, msxs, fibronectin, osteonectin and bone sialoprotein gene expression during normal and in vitro-induced odontoblast differentiation. Int J Dev Biol 1994; 38: 405-420.
59. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-684.